Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Vascular Medicine (London, England)|May 4, 2017
Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemiaGagan D Singh, Ehrin J Armstrong, Stephen W Waldo, et al.
The American Journal of Cardiology|February 4, 2021
Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program)Christopher P Kovach, Annika Hebbe, Colin I O'Donnell, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 17, 2017
Pregnancy associated plasma protein-A as a prognostic biomarker of all-cause mortality and cardiovascular events in patients presenting with chest pain: a systematic reviewChristos A Papanastasiou, Damianos G Kokkinidis, Evangelos K Oikonomou, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 7, 2020
Development and validation of a predictive score for anterograde crossing of infrapopliteal chronic total occlusions: (The Infrapop-CTO Score)Damianos G Kokkinidis, Aaron Strobel, Omar Jawaid, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 20, 2018
Midterm Outcomes After Endovascular Intervention for Occluded vs Stenosed External Iliac ArteriesDamianos G Kokkinidis, Bejan Alvandi, Prio Hossain, et al.
Circulation|November 14, 2014
Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary interventionStephen W Waldo, Eric A Secemsky, Cashel O'Brien, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 26, 2019
Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent RestenosisStefanos Giannopoulos, Damianos G Kokkinidis, Omar Jawaid, et al.
Circulation. Cardiovascular Quality and Outcomes|November 1, 2019
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System ProgramJoe X Xie, Elise C Gunzburger, Lindsay Kaun, et al.
JACC. Advances|January 18, 2025
The Quality of Veterans Healthcare Administration Cardiovascular CareD Elizabeth Le, Bhaskar L Arora, Faith R Kelly, et al.
American Heart Journal|November 13, 2023
Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021Taufiq Salahuddin, Annika Hebbe, Marguerite Daus, et al.
Pageof 15